Compugen Stock News

HOLON, Israel, Feb. 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management will present at the 11th Annual SVB Leerink Global Healthcare Conference (virtual), on…

HOLON, Israel, Feb. 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management w

The stock market and bond market remain historically overvalued today, however, the almost all-encompassing bubble has started to break. Learn more here.

Equities research analysts predict that Compugen Ltd. (NASDAQ:CGEN) will announce ($0.15) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Compugens earnings. The lowest EPS estimate is ($0.16) and the highest is ($0.12). Compugen reported earnings per share of ($0.10) during the same quarter []

Compugen Ltd. (NASDAQ:CGEN) price on Thursday, December 09, rose 1.30% above its previous days close as an upside momentum from buyers pushed the stocks value to $4.68. A look at the stocks price movement, the close in the last trading session was $4.62, moving within a range at $4.52 and $4.74. The beta value (5-Year Compugen Ltd. (CGEN) Has Recovered 21.37% From Its Low: Is This The Beginning Of A Trend? Read More »

Compugen has won Fortinets Achievement Award at the recently concluded NSE XPERTS Summit, a premier training event for elite technology professionals in cybersecurity. This award recognizes organizations for their technical achievements and commitment to strengthening their cybersecurity capabilities within the Fortinet fabric through Network Security Expert (NSE) certifications. This is the first time Compugen [PR.com]

Compugen Ltd. (NASDAQ:CGEN) shares, rose in value on Friday, 11/26/21, with the stock price down by -1.52% to the previous days close as strong demand from buyers drove the stock to $4.54. Actively observing the price movement in the last trading, the stock closed the session at $4.61, falling within a range of $4.48 and Compugen Ltd. (NASDAQ: CGEN) Is A Blank Check For Growth Read More »

3 penny stocks attracting attention from ARK Invest family of funds. The post 3 Penny Stocks Cathie Wood’s ARK Invest Bought In 2021, Will You? appeared first on Penny Stocks to Buy, Picks, News and

The trading price of Compugen Ltd. (NASDAQ:CGEN) closed higher on Tuesday, November 23, closing at $4.58, 1.10% higher than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

3 penny stocks attracting attention from ARK Invest family of funds. The post 3 Penny Stocks Cathie Wood's ARK Invest Bought In 2021, Will You?

Morgan Stanley boosted its holdings in shares of Compugen Ltd. (NASDAQ:CGEN) by 9.6% in the 2nd quarter, Holdings Channel reports. The firm owned 1,789,967 shares of the biotechnology companys stock after buying an additional 157,025 shares during the period. Morgan Stanleys holdings in Compugen were worth $14,820,000 at the end of the most recent reporting []

In the last trading session, 1.73 million shares of the Compugen Ltd. (NASDAQ:CGEN) were traded, and its beta was 2.26. Most recently the companys share price was $4.71, and it changed around -$0.1 or -2.08% from the last close, which brings the market valuation of the company to $403.60M. CGEN currently trades at a discount Could Compugen Ltd.s (NASDAQ: CGEN) Earnings Exceed Your Expectations? Read More »

Compugen Ltd. (CGEN) with the stream of -2.08% also noticed, India Histogen Inc. (HSTO) encountered a rapid change of -0.25% in the last hour of Fridays trading session. Compugen Ltd. The post Bright Stock Buzz: Compugen Ltd. (NASDAQ:CGEN), Histogen Inc. (NASDAQ:HSTO) appeared first on Stocks Equity .

Compugen Ltd. (NASDAQ:CGEN) Stock analysts at Jefferies Financial Group raised their FY2021 earnings per share (EPS) estimates for Compugen in a research report issued to clients and investors on Monday, November 15th. Jefferies Financial Group analyst C. Howerton now expects that the biotechnology company will post earnings per share of ($0.39) for the year, []

Compugen Ltd. (NASDAQ:CGEN)s traded shares stood at 1.81 million during the last session, with the companys beta value hitting 2.28. At the close of trading, the stocks price was $4.92, to imply a decrease of -4.65% or -$0.24 in intraday trading. The CGEN shares 52-week high remains $15.16, putting it -208.13% down since that peak After The Stock Fell -21.66% Over The Week, Is Compugen Ltd. (NASDAQ: CGEN) Still A Buy? Read More »